Immune checkpoint inhibitor‐associated myositis and myasthenia gravis overlap: Understanding the diversity in a case series

Immune checkpoint inhibitors (ICI) have improved survival across tumor types however they cause immune‐related toxicities through removal of the inhibition of auto‐reactive T cells. In this case review, we present 4 patients with metastatic cancer who developed de‐novo neuromuscular side effects of myositis with overlapping seropositive myasthenia gravis after ICI treatment. Declaration: This study was performed in accordance to the ethical...